These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11163328)

  • 1. Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.
    Kourounakis A; Visser C; de Groote M; IJzerman AP
    Biochem Pharmacol; 2001 Jan; 61(2):137-44. PubMed ID: 11163328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs.
    Bhattacharya S; Youkey RL; Ghartey K; Leonard M; Linden J; Tucker AL
    Biochem J; 2006 May; 396(1):139-46. PubMed ID: 16390330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
    Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor.
    Kollias-Baker CA; Ruble J; Jacobson M; Harrison JK; Ozeck M; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 1997 May; 281(2):761-8. PubMed ID: 9152383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunits.
    Klaasse E; de Ligt RA; Roerink SF; Lorenzen A; Milligan G; Leurs R; IJzerman AP
    Eur J Pharmacol; 2004 Sep; 499(1-2):91-8. PubMed ID: 15363955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
    Heitman LH; Mulder-Krieger T; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Dalpiaz A; IJzerman AP
    Br J Pharmacol; 2006 Mar; 147(5):533-41. PubMed ID: 16444290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
    Gao ZG; Melman N; Erdmann A; Kim SG; Müller CE; IJzerman AP; Jacobson KA
    Biochem Pharmacol; 2003 Feb; 65(4):525-34. PubMed ID: 12566079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.
    van der Klein PA; Kourounakis AP; IJzerman AP
    J Med Chem; 1999 Sep; 42(18):3629-35. PubMed ID: 10479294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
    Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
    J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release.
    Bueters TJ; van Helden HP; Danhof M; IJzerman AP
    Eur J Pharmacol; 2002 Nov; 454(2-3):177-82. PubMed ID: 12421644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A "locked-on," constitutively active mutant of the adenosine A1 receptor.
    de Ligt RA; Rivkees SA; Lorenzen A; Leurs R; IJzerman AP
    Eur J Pharmacol; 2005 Mar; 510(1-2):1-8. PubMed ID: 15740718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the adenosine A(1) receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranes.
    Jarvis MF; Gessner G; Shapiro G; Merkel L; Myers M; Cox BF; Martin GE
    Brain Res; 1999 Sep; 840(1-2):75-83. PubMed ID: 10517954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
    Bhattacharya S; Linden J
    Mol Pharmacol; 1996 Jul; 50(1):104-11. PubMed ID: 8700102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation.
    Gao ZG; Jiang Q; Jacobson KA; Ijzerman AP
    Biochem Pharmacol; 2000 Sep; 60(5):661-8. PubMed ID: 10927024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.
    Barbhaiya H; McClain R; Ijzerman A; Rivkees SA
    Mol Pharmacol; 1996 Dec; 50(6):1635-42. PubMed ID: 8967987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
    Cohen FR; Lazareno S; Birdsall NJ
    Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine.
    Kollias-Baker C; Ruble J; Dennis D; Bruns RF; Linden J; Belardinelli L
    Circ Res; 1994 Dec; 75(6):961-71. PubMed ID: 7955150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Zhou QY; Li C; Olah ME; Johnson RA; Stiles GL; Civelli O
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7432-6. PubMed ID: 1323836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.